PCSK9 inhibitors: clinical evidence and implementation
PCSK9 inhibitors: clinical evidence and implementation
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The gene encoding PCSK9 was first identified and linked to the phenotype of familial hypercholesterolaemia approximately 15 years ago. Soon after, studies uncovered the role of PCSK9 in the regulation of LDL-receptor recycling and identified loss-of-function variants of
PCSK9
that were associated with low circulating levels of LDL cholestero...
Alternative Titles
Full title
PCSK9 inhibitors: clinical evidence and implementation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2132736601
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2132736601
Other Identifiers
ISSN
1759-5002
E-ISSN
1759-5010
DOI
10.1038/s41569-018-0107-8
